Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global compounding pharmacies market is undergoing rapid transformation, driven by the increasing demand for personalized medications. These pharmacies formulate customized drugs for patients who need treatments not available in conventional forms, catering to specific needs such as allergies, age-based dosage requirements, or unique drug combinations. With healthcare steadily shifting toward personalized and precision medicine, compounding pharmacies are emerging as a vital part of modern pharmaceutical care.

Market Insights

Fairfield Market Research estimates that the global compounding pharmacies market will grow from US$ 10.9 billion in 2025 to US$ 17 billion by 2032, reflecting a steady compound annual growth rate (CAGR) of 6.56%. This growth is driven by rising patient preference for tailor-made treatments, expanding therapeutic applications, and increasing acceptance among physicians and healthcare providers.

Key Market Drivers

Several factors are fueling the growth of compounding pharmacies globally. A major driver is the increasing incidence of chronic illnesses, which often require specific dosages and combinations of drugs that are not available in commercially mass-produced medications. Additionally, compounding pharmacies are critical in addressing drug shortages and discontinuations by preparing alternative formulations.

The demand for hormone replacement therapy (HRT) has significantly contributed to market expansion. With growing awareness about hormonal imbalances and related health conditions, compounded HRT options like progesterone, estradiol, and testosterone are seeing increased utilization. These therapies offer the advantage of customized dosing, particularly beneficial for aging populations.

Business Opportunities

Emerging opportunities in the market include the development of advanced drug delivery systems such as flavored suspensions, lollipops, and topical gels tailored to patient preferences. These innovations increase adherence and improve therapeutic outcomes, especially among pediatric and geriatric populations.

Pharmacies are also adopting hybrid models by integrating compounding services with retail operations to diversify revenue streams and enhance patient accessibility. The expanding use of bio-identical hormone replacement therapy (BHRT), particularly in North America, Europe, and Asia-Pacific, is expected to further accelerate market growth.

Strategic acquisitions, partnerships with raw material suppliers, and investments in research and development are helping compounding pharmacy players strengthen their position and expand into new markets.

Regional Analysis

United States:

The U.S. dominates the compounding pharmacies market in North America, supported by a high prevalence of dermatological and chronic conditions and the growing need for customized treatment options. Online compounding pharmacies and BHRT formulations are particularly popular.

Germany:

Germany is a key growth market in Europe, driven by a rising elderly population and increasing demand for age-specific medications. With the aging demographic seeking anti-aging and hormonal therapies, demand for compounding services is on the rise.

Australia:

Australia is emerging as a notable market due to increasing demand for hormone-related therapies, particularly for menopause. Compounding pharmacists are playing a key role in formulating personalized BHRT treatments using various dosage forms such as creams, capsules, and suppositories.

Key Growth Drivers

Leading companies in the compounding pharmacies space include:
• Fagron
• Fresenius Kabi AG
• PharMEDium Services LLC
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Lorraine’s Pharmacy
• B. Braun Melsungen AG Company

These players are focusing on innovation, strategic partnerships, and geographic expansion. Noteworthy developments include new production facilities, expansion into regulated markets, and collaborations with technology providers to enhance formulation and safety.

Market Segmentation

By Product:
• Oral Medications

Capsules

Tablets

Mixtures

Lollipops

Lozenges
• Topical Medications

Gels

Ointments

Creams

Lotions

Mouthwashes
• Suppositories

By Application:
• Medication for Adults
• Medication for Children
• Medication for Geriatric Patients
• Medication for Veterinary Use

By Therapeutic Area:
• Pain Management
• Hormone Replacement Therapy

By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Compounding Pharmacies Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Compounding Pharmacies Market Outlook, 2019-2032
3.1. Global Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Oral Medication
3.1.1.1.1. Capsules
3.1.1.1.2. Tablets
3.1.1.1.3. Mixtures
3.1.1.1.4. Lollipops
3.1.1.1.5. Lozenges
3.1.1.2. Topical Medications
3.1.1.2.1. Gels
3.1.1.2.2. Ointments
3.1.1.2.3. Cream
3.1.1.2.4. Lotions
3.1.1.3. Mouthwashes
3.1.1.4. Suppositories
3.2. Global Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Medication for Adults
3.2.1.2. Medication for Veterinary
3.2.1.3. Medication for Children
3.2.1.4. Medication for Geriatric
3.3. Global Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Pain Management
3.3.1.2. Hormone Replacement Therapy
3.4. Global Compounding Pharmacies Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Compounding Pharmacies Market Outlook, 2019-2032
4.1. North America Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Oral Medication
4.1.1.1.1. Capsules
4.1.1.1.2. Tablets
4.1.1.1.3. Mixtures
4.1.1.1.4. Lollipops
4.1.1.1.5. Lozenges
4.1.1.2. Topical Medications
4.1.1.2.1. Gels
4.1.1.2.2. Ointments
4.1.1.2.3. Cream
4.1.1.2.4. Lotions
4.1.1.3. Mouthwashes
4.1.1.4. Suppositories
4.2. North America Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Medication for Adults
4.2.1.2. Medication for Veterinary
4.2.1.3. Medication for Children
4.2.1.4. Medication for Geriatric
4.3. North America Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Pain Management
4.3.1.2. Hormone Replacement Therapy
4.4. North America Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Compounding Pharmacies Market Outlook, 2019-2032
5.1. Europe Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Oral Medication
5.1.1.1.1. Capsules
5.1.1.1.2. Tablets
5.1.1.1.3. Mixtures
5.1.1.1.4. Lollipops
5.1.1.1.5. Lozenges
5.1.1.2. Topical Medications
5.1.1.2.1. Gels
5.1.1.2.2. Ointments
5.1.1.2.3. Cream
5.1.1.2.4. Lotions
5.1.1.3. Mouthwashes
5.1.1.4. Suppositories
5.2. Europe Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Medication for Adults
5.2.1.2. Medication for Veterinary
5.2.1.3. Medication for Children
5.2.1.4. Medication for Geriatric
5.3. Europe Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Pain Management
5.3.1.2. Hormone Replacement Therapy
5.4. Europe Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.7. France Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.8. France Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.9. France Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Compounding Pharmacies Market Outlook, 2019-2032
6.1. Asia Pacific Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Oral Medication
6.1.1.1.1. Capsules
6.1.1.1.2. Tablets
6.1.1.1.3. Mixtures
6.1.1.1.4. Lollipops
6.1.1.1.5. Lozenges
6.1.1.2. Topical Medications
6.1.1.2.1. Gels
6.1.1.2.2. Ointments
6.1.1.2.3. Cream
6.1.1.2.4. Lotions
6.1.1.3. Mouthwashes
6.1.1.4. Suppositories
6.2. Asia Pacific Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Medication for Adults
6.2.1.2. Medication for Veterinary
6.2.1.3. Medication for Children
6.2.1.4. Medication for Geriatric
6.3. Asia Pacific Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Pain Management
6.3.1.2. Hormone Replacement Therapy
6.4. Asia Pacific Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.2. China Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.3. China Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.10. India Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.11. India Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.12. India Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Compounding Pharmacies Market Outlook, 2019-2032
7.1. Latin America Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Oral Medication
7.1.1.1.1. Capsules
7.1.1.1.2. Tablets
7.1.1.1.3. Mixtures
7.1.1.1.4. Lollipops
7.1.1.1.5. Lozenges
7.1.1.2. Topical Medications
7.1.1.2.1. Gels
7.1.1.2.2. Ointments
7.1.1.2.3. Cream
7.1.1.2.4. Lotions
7.1.1.3. Mouthwashes
7.1.1.4. Suppositories
7.2. Latin America Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1. Key Highlights
7.2.1.1. Medication for Adults
7.2.1.2. Medication for Veterinary
7.2.1.3. Medication for Children
7.2.1.4. Medication for Geriatric
7.3. Latin America Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Pain Management
7.3.1.2. Hormone Replacement Therapy
7.4. Latin America Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Compounding Pharmacies Market Outlook, 2019-2032
8.1. Middle East & Africa Compounding Pharmacies Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Oral Medication
8.1.1.1.1. Capsules
8.1.1.1.2. Tablets
8.1.1.1.3. Mixtures
8.1.1.1.4. Lollipops
8.1.1.1.5. Lozenges
8.1.1.2. Topical Medications
8.1.1.2.1. Gels
8.1.1.2.2. Ointments
8.1.1.2.3. Cream
8.1.1.2.4. Lotions
8.1.1.3. Mouthwashes
8.1.1.4. Suppositories
8.2. Middle East & Africa Compounding Pharmacies Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Medication for Adults
8.2.1.2. Medication for Veterinary
8.2.1.3. Medication for Children
8.2.1.4. Medication for Geriatric
8.3. Middle East & Africa Compounding Pharmacies Market Outlook, by Therapeutic Area, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Pain Management
8.3.1.2. Hormone Replacement Therapy
8.4. Middle East & Africa Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Compounding Pharmacies Market by Product, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Compounding Pharmacies Market by Application, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Compounding Pharmacies Market Therapeutic Area, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Therapeutic Area Heatmap
9.2. Manufacturer vs Therapeutic Area Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Fagron
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Fresenius Kabi AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. PharMEDium Services LLC
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Institutional Pharmacy Solutions
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Cantrell Drug Company
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Lorraine’s Pharmacy
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. B. Braun Melsungen AG Company
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings